evolution of therapy in lung cancer - 2022 program: targeted therapies forum
Published 1 year ago • 98 plays • Length 4:55Download video MP4
Download video MP3
Similar videos
-
6:13
evolving treatment for nsclc: targeted therapies - 2022 program: targeted therapies forum
-
8:09
kras nsclc: prevalence and the evolution of treatment - 2022 program: targeted therapies forum
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
7:49
alk nsclc treatment options - 2022 program: targeted therapies forum
-
1:57
alk nsclc: what does it mean? - 2022 program: targeted therapies forum
-
7:27
intro and cancer 101 - grace targeted therapies in lung cancer patient forum 2021
-
7:20
treatment of her2 nsclc - 2022 program: targeted therapies forum
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
3:21
treatment timelines for kras nsclc - 2022 program: targeted therapies forum - english
-
5:35
progression on sotorasib with kras nsclc - 2022 program: targeted therapies forum
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
7:27
trials in her2 nsclc - 2022 program: targeted therapies forum
-
3:20
her2 nsclc: when to introduce targeted therapies - 2022 program: targeted therapies forum
-
3:21
when should progression lead to treatment changes? - 2022 program: targeted therapies forum
-
2:45
kras mutations in advanced nsclc - 2022 program: targeted therapies forum - english
-
7:53
ret nsclc treatment options - 2022 program: targeted therapies forum
-
3:13
changes in the field of metastatic nsclc - 2022 program: targeted therapies forum - english
-
3:55
disease progression on lorlatinib or osimertinib - 2022 program: targeted therapies forum
-
4:31
types of biopsies for kras nsclc - 2022 program: targeted therapies forum